Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
15/06/2026 23:48
BRIEF-Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026 June 15 (Reuters) - Ironwood Pharmaceuticals Inc IRWD.O:
IRONWOOD PHARMACEUTICALS - REPAID IN FULL $200 MILLION 1.5% CONVERTIBLE SENIOR NOTES DUE 2026 - SEC FILING
IRONWOOD PHARMACEUTICALS - FUNDED REPAYMENT OF NOTES USING AVAILABLE CASH ON HAND - SEC FILING
Source text: [ID:n0001104659-26-074023]
Further company coverage: IRWD.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation